What is the level of liabilities of PhenomeX this year?
PhenomeX has a debt balance of 84 M USD this year.
PhenomeX Liabilities 2024
PhenomeX Liabilities
84 M USD
Ticker
CELL
ISIN
US0843101017
WKN
A2P9RR
In 2024, PhenomeX's total liabilities amounted to 84 M USD, a 6.33% difference from the 79 M USD total liabilities in the previous year.
PhenomeX Aktienanalyse
What does PhenomeX do?
The company Berkeley Lights Inc. (BLI) is a biotech startup that was founded in 2011 by Eric Hobbs and Igor Khandros in California. They both had experience in the semiconductor electronics field and decided to utilize their skills to develop a new technology that allows researchers to quickly and efficiently investigate cell-specific processes. The concept behind BLI is based on a novel technology called the "Beacon system." Cells are held on thousands of tiny microchips and can be selectively manipulated using beams of light. The Beacon system enables researchers to isolate, analyze, and select cells rapidly and efficiently, significantly speeding up and simplifying the research process. BLI's business model can be described as B2B, as the company sells its technology and services to other companies in the biotech industry. BLI has two different divisions in which it utilizes its technology and expertise: the "OptoSelect" program and the "Beacon Discovery" program. BLI's OptoSelect program offers customers the ability to select precise and specific cell lines from a large array of cultures. BLI utilizes its Beacon technology to quickly and efficiently isolate and select cells, saving valuable time and resources for researchers. These cell lines can then be used in the development of drugs and therapies, increasing the chances of successful market introduction. BLI's Beacon Discovery program is focused on accelerating the discovery process of new drugs and therapies. BLI works closely with its customers to expedite the drug development process. By using the Beacon technology, it is possible to identify and test potential drug candidates more quickly, significantly reducing the development time. BLI also offers a range of products based on the Beacon technology. These include devices such as the Lightning™ Digital Array, a system for multi-omics analysis of gene expression, immune response, and cell cycle; the Beacon® Controller, a system for controlling the Beacon® microchip platform; and the Beacon® Pak for consumables. Since its founding, BLI has conducted multiple funding rounds and raised over $180 million for the development of its technology and services. The company has established strong partnerships with leading companies in the biotech industry and collaborates closely with researchers and universities to advance its technology. Overall, BLI has established itself as a leading provider of biotech technologies. Through the use of its Beacon technology, the company has accelerated and simplified the process of cell analysis and selection, speeding up the development of new drugs and therapies and increasing the chances of successful market introduction. With its state-of-the-art products and services, BLI is well-positioned to continue playing a significant role in the biotech industry in the future. PhenomeX ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing PhenomeX's Liabilities
PhenomeX's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating PhenomeX's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing PhenomeX's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
PhenomeX's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in PhenomeX’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about PhenomeX stock
What were the liabilities of PhenomeX compared to the previous year?
The liabilities of PhenomeX have increased by 6.33% increased compared to the previous year.
What are the consequences of high debt for investors of PhenomeX?
High liabilities can pose a risk for investors of PhenomeX, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in PhenomeX?
Low liabilities mean that PhenomeX has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of PhenomeX affect the company?
An increase in liabilities of PhenomeX can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of PhenomeX affect the company?
A decrease in the liabilities of PhenomeX can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of PhenomeX?
Some factors that can influence the liabilities of PhenomeX include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of PhenomeX so important for investors?
The liabilities of PhenomeX are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can PhenomeX take to modify the liabilities?
To change its liabilities, PhenomeX can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does PhenomeX pay?
Over the past 12 months, PhenomeX paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, PhenomeX is expected to pay a dividend of 0 USD.
What is the dividend yield of PhenomeX?
The current dividend yield of PhenomeX is .
When does PhenomeX pay dividends?
PhenomeX pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of PhenomeX?
PhenomeX paid dividends every year for the past 0 years.
What is the dividend of PhenomeX?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is PhenomeX located?
PhenomeX is assigned to the 'Health' sector.
Wann musste ich die Aktien von PhenomeX kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of PhenomeX from 11/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 11/17/2024.
When did PhenomeX pay the last dividend?
The last dividend was paid out on 11/17/2024.
What was the dividend of PhenomeX in the year 2023?
In the year 2023, PhenomeX distributed 0 USD as dividends.
In which currency does PhenomeX pay out the dividend?
The dividends of PhenomeX are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von PhenomeX
Our stock analysis for PhenomeX Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of PhenomeX Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.